Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy.
Blood ( IF 21.0 ) Pub Date : 2022-03-03 , DOI: 10.1182/blood.2021014989 Evangelos Terpos 1 , Maria Gavriatopoulou 1 , Ioannis Ntanasis-Stathopoulos 1 , Alexandros Briasoulis 1 , Sentiljana Gumeni 2 , Panagiotis Malandrakis 1 , Eleni-Dimitra Papanagnou 2 , Magdalini Migkou 1 , Nikolaos Kanellias 1 , Efstathios Kastritis 1 , Ioannis P Trougakos 2 , Meletios A Dimopoulos 1
中文翻译：
增强剂 BNT162b2 优化骨髓瘤患者的 SARS-CoV-2 体液反应：抗 BCMA 治疗的负面影响。
更新日期：2022-01-05
Blood ( IF 21.0 ) Pub Date : 2022-03-03 , DOI: 10.1182/blood.2021014989 Evangelos Terpos 1 , Maria Gavriatopoulou 1 , Ioannis Ntanasis-Stathopoulos 1 , Alexandros Briasoulis 1 , Sentiljana Gumeni 2 , Panagiotis Malandrakis 1 , Eleni-Dimitra Papanagnou 2 , Magdalini Migkou 1 , Nikolaos Kanellias 1 , Efstathios Kastritis 1 , Ioannis P Trougakos 2 , Meletios A Dimopoulos 1
Affiliation
中文翻译：
增强剂 BNT162b2 优化骨髓瘤患者的 SARS-CoV-2 体液反应：抗 BCMA 治疗的负面影响。
京公网安备 11010802027423号